144 results
Page 3 of 8
8-K
fkin0g 5sh2ldg7f
8 May 20
AbbVie Completes Transformative Acquisition of Allergan
4:31pm
8-K
EX-99.1
1edclf
7 Feb 20
AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
7:48am
8-K
EX-4.2
kjok2d61s0
26 Nov 19
Entry into a Material Definitive Agreement
8:45am
8-K
EX-99.1
vtzobjzl2
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-1.1
gyfo4f1 q4j
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-4.2
w13d5hv
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.3
16ta4zr
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-5.1
moq87lipn emp9sdfsg
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-1.1
6pc k80puv
23 Sep 19
Entry into a Material Definitive Agreement
4:24pm
424B5
e4m74d7zkvqldnnwnvk
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
vg9x5e4
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-10.1
xa5pt
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
8trmyv8o5o 80wiur
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
fy7c fyqv2qgjrjebb
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
fy0 yzisbz
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
om5zkozicac
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm